MOVIPREP- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate kit United States - English - NLM (National Library of Medicine)

moviprep- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate kit

salix pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 100 g in 1 l - moviprep® is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. moviprep is contraindicated in the following conditions: risk summary there are no available data on moviprep in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with moviprep. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available on the presence of moviprep in human milk, the effects of the drug on the breastfed child, or the effects of the drug on milk production. the lack of clinical data during lactation precludes a clear determination of the risk o

Vipera Redi Boiron 5CH pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 5ch pilules

boiron - vipera redi 5ch 1 % - pillules - 5ch - vipera redi 5ch 1 %

Vipera Redi Boiron 7CH pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 7ch pilules

boiron - vipera redi 7ch 1 % - pillules - 7ch - vipera redi 7ch 1 %

Vipera Redi Boiron 9CH pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 9ch pilules

boiron - vipera redi 9ch 1 % - pillules - 9ch - vipera redi 9ch 1 %

Vipera Redi Boiron 30K pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 30k pilules

boiron - vipera redi 30k 1 % - pillules - 30k - vipera redi 30k 1 %

Vipera Redi Boiron 200K pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 200k pilules

boiron - vipera redi 200k 1 % - pillules - 200k - vipera redi 200k 1 %

Vipera Redi Boiron XMK pilules Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron xmk pilules

boiron - vipera redi xmk 1 % - pillules - xmk - vipera redi xmk 1 %

Vipera Redi Boiron 200K pilules single-dose cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vipera redi boiron 200k pilules single-dose cont.

boiron - vipera redi 200k 1 % - pillules in single-dose container - 200k - vipera redi 200k 1 %

CLEVIPREX clevidipine, 50 mg in 100 mL injectable emulsion, Single Use Vials Australia - English - Department of Health (Therapeutic Goods Administration)

cleviprex clevidipine, 50 mg in 100 ml injectable emulsion, single use vials

chiesi australia pty ltd - clevidipine, quantity: 50 mg - injection, emulsion - excipient ingredients: soya oil; glycerol; egg lecithin; water for injections; sodium hydroxide; oleic acid; disodium edetate - cleviprex is indicated for the short term treatment of hypertension when oral therapy is not feasible or desirable.

CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials Australia - English - Department of Health (Therapeutic Goods Administration)

cleviprex clevidipine, 25 mg in 50 ml injectable emulsion, single use vials

chiesi australia pty ltd - clevidipine, quantity: 25 mg - injection, emulsion - excipient ingredients: water for injections; glycerol; soya oil; egg lecithin; sodium hydroxide; oleic acid; disodium edetate - cleviprex is indicated for the short term treatment of hypertension when oral therapy is not feasible or desirable.